Canaccord Genuity Assumes Theratechnologies at Hold, Announces Price Target of $2
Portfolio Pulse from richadhand@benzinga.com
Canaccord Genuity analyst Edward Nash assumes Theratechnologies (NASDAQ:THTX) with a Hold rating and announces a price target of $2.
July 03, 2023 | 1:02 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Canaccord Genuity has assumed Theratechnologies with a Hold rating and set a price target of $2.
The news directly pertains to Theratechnologies (THTX) as Canaccord Genuity has assumed the company with a Hold rating. This suggests that the analyst believes the stock will perform in line with the market or sector in the short term. The price target of $2 also provides a benchmark for investors. This could potentially influence the stock's performance in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100